Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market
Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
The surgeons were able to remove the entire breast while preserving the nipple through tiny hidden incisions
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
Both organisations enter into a long- term collaboration to expand patient access in India
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
The drug will target specific genetic mutations prevalent in certain types of cancers
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Subscribe To Our Newsletter & Stay Updated
